The US Food and Drug Administration has granted orphan drug designation (ODD) to Tempest Therapeutics' oral, selective ...

Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in ...

The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications ...

MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.

MAIA Biotechnology (MAIA) announced that it has entered into a clinical supply agreement with BeiGene (BGNE) to assess the efficacy of THIO, ...

Patients with indeterminate chronic hepatitis B (CHB) phase are at risk of progressing to advanced liver disease and hepatocellular carcinoma (HCC), according to study results published in the Journal ...

Arizona patient dies after contracting donor's lung cancer, exposing rare transplant risks and screening challenges.

Surgeons at the Mahatma Gandhi Memorial Government Hospital (MGMGH) in Tiruchi have removed a tumour weighing 1.5 kg from the right lobe of a patient’s liver and saved his life on Monday ...

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral ...

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal ...

A new study reveals that certain diets, particularly those high in fat and sugar, could significantly increase the risk of ...